Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20
Published March 27, 2024 · Recall initiated: March 4, 2024
Summary
FDA records drug Class III recall D-0389-2024, published March 27, 2024 and initiated March 4, 2024. Recalling firm: Novitium Pharma LLC; Status: Terminated; Reported quantity: 3,940 1000-count bottles; Lot: Lot #: M23172A, Exp 01/31/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products:(mycophenolate mofetil).
What to do
Voluntary: Firm initiated · Letter
Get an email if DIGOXIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIGOXIN
- Manufacturer
- Novitium Pharma LLC
- Distributor
- Nationwide in the USA
- UPC
- 0370954201106
- Lot
- Lot #: M23172A, Exp 01/31/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADigoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC,April 24, 2024
- FDANicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by:March 27, 2024
- FDANicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics PharmaMarch 27, 2024
- FDASPII Model Lubinus, Long Stem Prosthesis XL Neck, cementedMarch 20, 2024
- FDASPII Model Lubinus, Long Stem Prosthesis Standard Neck, cementedMarch 20, 2024
- FDASPII Model Lubinus, Hip Prosthesis Stem XL Neck, cementedMarch 20, 2024
Questions about this recall
Was Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20 recalled?
Yes. FDA published recall D-0389-2024 on March 27, 2024. Reported hazard: Cross Contamination with Other Products:(mycophenolate mofetil).
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIGOXIN. UPC: 0370954201106.